Mr. Casdin is currently Vice President, Finance at Amylin Pharmaceuticals, overseeing Financial Planning and Analysis, Investor Relations and Treasury. Prior to joining Amylin in November 2009, Mr. Casdin was founder of Casdin Advisors LLC where he served as a strategic advisor to the Life Sciences industry. In addition, he is a member of the advisory board of the Social Enterprise Program at Columbia Business School. Before founding Casdin Advisors in 2008, Mr. Casdin, an investment professional, worked as CEO and Portfolio Manager of Cooper Hill Partners, a healthcare investment fund. He joined Cooper Hill in September 2001 from Pequot Capital Management, where he was the Portfolio Manager of the Pequot Healthcare Fund. Prior to that, Mr. Casdin worked at the Dreyfus Corporation as a health care analyst, covering all areas of health care including pharmaceuticals, biotechnology, and medical device companies. He holds an MBA from Columbia Business School and a Bachelor’s degree from Brown University.